A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Injected Azacitidine in Colombia

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Acute Myeloid Leukemia
Trial Locations (7)

50010

ACTIVE_NOT_RECRUITING

Hospital Alma Mater de Antioquia /ID# 248562, Medellin

110111

RECRUITING

Fundación Santa Fé De Bogotá /ID# 248563, Bogotá

110231

RECRUITING

Clinica del Country /ID# 248430, Bogota

111221

ACTIVE_NOT_RECRUITING

Coorp Hosp Juan Ciudad Sede Hospital Universitario Mayor Mederi /ID# 248570, Bogota DC

200001

RECRUITING

Sociedad de Oncologia y Hematologia del Cesar /ID# 248615, Valledupar

760016

ACTIVE_NOT_RECRUITING

Fundación Valle Del Lili /ID# 248294, Santiago de Cali

050034

RECRUITING

Hospital Pablo Tobón Uribe /ID# 248569, Medellín

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY